Cargando…
Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase
IL (interleukin)-6, an established growth factor for multiple myeloma cells, induces myeloma therapy resistance, but the resistance mechanisms remain unclear. The present study determines the role of IL-6 in re-establishing intracellular redox homoeostasis in the context of myeloma therapy. IL-6 tre...
Autores principales: | Brown, Charles O., Salem, Kelley, Wagner, Brett A., Bera, Soumen, Singh, Neeraj, Tiwari, Ajit, Choudhury, Amit, Buettner, Garry R., Goel, Apollina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365439/ https://www.ncbi.nlm.nih.gov/pubmed/22471522 http://dx.doi.org/10.1042/BJ20112019 |
Ejemplares similares
-
Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma
por: Salem, Kelley, et al.
Publicado: (2014) -
Manganese Superoxide Dismutase: Guardian of the Powerhouse
por: Holley, Aaron K., et al.
Publicado: (2011) -
The Role of Manganese Superoxide Dismutase in Inflammation Defense
por: Li, Chang, et al.
Publicado: (2011) -
The Role of Manganese Superoxide Dismutase in Skin Cancer
por: Robbins, Delira, et al.
Publicado: (2011) -
The role of manganese superoxide dismutase in skin aging
por: Treiber, Nicolai, et al.
Publicado: (2012)